Project Grant R36AG087309

Award Date 7/1/24
Completion Date 6/30/25
Dollars Obligated $104K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $572,203 to the Regents of the University of Michigan to conduct research on mechanisms for preserving muscle function during aging. The research aims to define cellular responses and molecular pathways critical for motor unit expansion, a compensatory mechanism that helps maintain muscle under conditions of denervation. Specifically, the project will examine how aging and denervation...
This Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $270,114 to the Oklahoma Medical Research Foundation (OMRF) to investigate the role of the transcription factor TFEB as a critical node for improving proteostatic maintenance and skeletal muscle function with aging. The project aims to determine if increasing TFEB activity can improve the maintenance of muscle mass and function in aged mice (Aim 1), whether mTOR activity...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Texas Medical Branch at Galveston is funding research to investigate the effects of age-related post-translational modifications on the stability and function of the myosin protein and its chaperone UNC-45. The $576,893 award, spanning September 2024 to May 2029, aims to elucidate how these chemical modifications contribute to the loss of muscle mass and function associated with...
This $381,507 Project Grant was awarded by the National Institute on Aging under the Aging Research federal grant program (CFDA 93.866) to the University of Iowa. The grant aims to study the role of the protein kinase ULK2 and its binding partner FIP200 in the selective degradation of protein aggregates in skeletal muscle, which could contribute to the development of age-related muscle atrophy and weakness (sarcopenia). The proposed research has two key objectives: 1) Establish ULK2's role in...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, CFDA 93.846) provides $248,724 to the University of Alabama at Birmingham (UAB) to conduct research on the role of cellular senescence in skeletal muscle loss and dysfunction. The overarching objectives are to (1) obtain the necessary skills and training to develop a translational research program investigating mechanisms underlying skeletal muscle wasting, and (2) generate data to...
The National Institute on Aging awarded a $151,000 Project Grant (CFDA 93.866 Aging Research) to Ohio University to investigate the role of the keratin 18 protein in mediating skeletal muscle adaptation to exercise and age-related muscle loss (sarcopenia). The overarching goal is to determine if the upregulation of keratin 18 facilitates skeletal muscle resilience and adaptation to physical stress, especially in older individuals susceptible to sarcopenia and frailty. The project will examine...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $3,343,725.00 in funding to The Spaulding Rehabilitation Hospital Corporation to investigate the effects of muscle aging and activity on extracellular vesicle promotion of muscle regeneration. The award period runs from August 15, 2024 to April 30, 2029. Key aims of the study include: 1) Examining how aging of the skeletal muscle extracellular matrix alters the molecular cargoes of...
This Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), provides $287,218.16 in funding to the University of Maryland, Baltimore from August 1, 2021 through March 27, 2022. The award supports research aimed at better understanding the impact of aging on muscle excitability and action potential conduction velocity. Specifically, the recipient will use electrophysiology techniques and optical imaging to examine...
The National Institute on Aging (NIA) awarded a 2-year, $227,250 Project Grant (CFDA 93.866 - Aging Research) to Saint Louis University to conduct research on the role of the protease Cathepsin L in modulating the nuclear proteome and cellular response to nuclear damage. The research aims to elucidate how Cathepsin L cleavage of nuclear architectural proteins like Lamin A/C, Lamin B1, and Lamin B2 impacts cellular processes related to aging, age-associated diseases such as Alzheimer's, and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $116,710 to Duke University to support Dr. David Lee's research on fibro/adipogenic progenitor (FAP) cell metabolism and its role in age-related muscle fibrosis and sarcopenia. The research aims to 1) determine the onset of FAP fibrogenesis during sarcopenia development, 2) assess whether increased FAP glycolysis drives fibrogenesis, and 3) investigate if Wnt signaling regulates FAP glycolysis and...

LAMIN A/C IS REQUIRED FOR MAINTAINING SUBSYNAPTIC MYONUCLEI INTEGRITY - PROJECT SUMMARY / ABSTRACT SARCOPENIA, THE AGE-RELATED DECLINE IN SKELETAL MUSCLE MASS AND FORCE, IS CHARACTERIZED BY MUSCLE WASTING AND DIMINISHED CONTRACTILE STRENGTH LEADING TO PHYSICAL FRAILTY, DECREASED MOBILITY, INCREASED DISABILITY, AND A LOSS OF INDEPENDENCE. THE NEUROMUSCULAR JUNCTION (NMJ) IS THE SYNAPSE RESPONSIBLE FOR TRANSMITTING ACTION POTENTIALS FROM MOTOR NEURONS TO THE MOTOR ENDPLATE OF MUSCLE FIBERS. NMJS EXHIBIT STRUCTURAL AND FUNCTIONAL DISRUPTIONS INCLUDING A COMPLETE LOSS OF INNERVATION DURING AGING, BUT THE MECHANISMS FOR THIS DETRIMENTAL PHENOTYPE REMAIN UNKNOWN. THIS STUDY AIMS TO INVESTIGATE THE ROLE IN NMJ DEGENERATION OF CHANGES IN SUBSYNAPTIC MYONUCLEI (SSM). SKELETAL MUSCLE FIBERS ARE LARGE MULTINUCLEATED CELLS, WITH DIFFERENT INDIVIDUAL NUCLEI RESPONSIBLE FOR SUPPORTING LOCALIZED DOMAINS. SSM ARE A POPULATION OF NUCLEI POSITIONED NEAR THE NMJ THAT PLAY A CRUCIAL ROLE IN NMJ DEVELOPMENT AND MAINTENANCE. PREVIOUS STUDIES HAVE PRODUCED CONFLICTING RESULTS REGARDING ASSOCIATIONS BETWEEN AGING, SSM NUMBER, AND NMJ DEGENERATION EMPHASIZING THE NEED FOR FURTHER INVESTIGATIONS TO CLARIFY THE ROLE OF CHANGES IN SSM AS POTENTIAL CAUSE OR CONSEQUENCE OF A LOSS OF INNERVATION. OUR OWN DATA INDICATES NO CHANGE IN SSM NUMBER WITH AGE, DESPITE HIGH NUMBERS OF DISRUPTED AND DENERVATED ENDPLATES IN MUSCLES OF OLD ANIMALS. WE ALSO FOUND NO CHANGES IN SSM NUMBER FOLLOWING ACUTE DENERVATION, BUT DENERVATED MUSCLES SHOWED A SIGNIFICANT INCREASE IN LMNA GENE EXPRESSION AS WELL AS IN THE LEVELS OF THE PROTEIN PRODUCT LAMIN A/C. LAMIN A/C IS THE PRIMARY INTERMEDIATE FILAMENT PROTEIN OF THE NUCLEAR LAMINA AND A KEY COMPONENT IN MAINTAINING MYONUCLEAR STRUCTURAL INTEGRITY. THE NUCLEAR LAMINA PLAYS A CRITICAL ROLE IN REGULATING GENE EXPRESSION BY INTERACTING WITH CHROMATIN AND NUCLEAR MEMBRANE PROTEINS. THE EXPRESSION OF LAMIN A/C HAS BEEN REPORTED TO DECREASE WITH AGE, AND ITS MUSCLE-SPECIFIC DELETION ACCELERATES NMJ DEGRADATION, RESEMBLING AGE-RELATED NMJ DECLINE. OUR OVERALL HYPOTHESIS IS THAT LAMIN A/C IS REQUIRED FOR MEDIATING THE PROCESS OF REINNERVATION FOLLOWING A DENERVATION EVENT. WE WILL ADDRESS THIS HYPOTHESIS USING A COMBINATION OF POWERFUL MOUSE MODELS, SURGICAL INTERVENTIONS, ASSESSMENTS OF NEUROMUSCULAR FUNCTIONAL PROPERTIES, AND AN ARRAY OF MOLECULAR TECHNIQUES COMBINED WITH HIGH-RESOLUTION CONFOCAL IMAGING. SPECIFICALLY, WE WILL [1] DEFINE THE IMPACT OF DENERVATION ON THE INTEGRITY OF SUBSYNAPTIC MYONUCLEI IN YOUNG AND AGED MICE, AND [2] DETERMINE THE IMPACT OF SKELETAL MUSCLE-SPECIFIC LMNA DELETION ON REINNERVATION FOLLOWING NERVE INJURY. WE EXPECT TO SEE A DENERVATION- INDUCED UPREGULATION OF LAMIN A/C THAT CONTRIBUTES TO THE MAINTENANCE SSM SHAPE AND SSM NUMBER LEADING TO IMPROVED REINNERVATION OF ENDPLATES. THEREFORE, WE ALSO PREDICT THAT LACK OF LAMIN A/C WILL RESULT IN IMPAIRED REINNERVATION AFTER NERVE INJURY LEADING TO POOR NEUROMUSCULAR FUNCTION. BY ELUCIDATING KEY REGULATORS OF REINNERVATION, WE AIM TO IDENTIFY THERAPEUTIC TARGETS FOR PHYSIOLOGICAL MANIPULATION TO BOOST COMPENSATORY MECHANISMS THAT DRIVE REINNERVATION, EXTEND HEALTHSPAN, AND ENHANCE QUALITY OF LIFE FOR THE ELDERLY.

Posted 6/20/24, 12:00 AM